Comparative Histological, Immunohistochemical, and Biochemical Effects of Three Orally Administered Fluoroquinolones in Rats

dc.contributor.author Yaman, Turan
dc.contributor.author Donmez, Fatih
dc.contributor.author Dogan, Abdulahad
dc.contributor.author Battal, Abdulhamit
dc.date.accessioned 2025-10-30T15:26:00Z
dc.date.available 2025-10-30T15:26:00Z
dc.date.issued 2025
dc.description.abstract Fluoroquinolones (FQs) are potent, broad-spectrum bactericidal antibiotics commonly used to treat infections in both humans and animals. Despite their therapeutic efficacy, their potential reproductive toxicity remains a concern. This study aimed to evaluate the histological, immunohistochemical, and biochemical effects of three FQ derivatives-ciprofloxacin (CIP), levofloxacin (LVX), and moxifloxacin (MXF)-on the testicular tissue of rats over different time intervals. Seventy-two male Wistar albino rats were randomly divided into four groups (n = 18): Control, CIP (80 mg/kg), LVX (40 mg/kg), and MXF (40 mg/kg). Treatments were administered orally, and testicular samples were collected at three time points (Day 1, 7, and 14). Histopathological evaluation was performed using hematoxylin and eosin staining. Cyclooxygenase-2 (COX-2) expression was assessed immunohistochemically. Biochemical analyses included measurements of malondyaldehyde (MDA), adenosine deaminase (ADA), and acetylcholine esterase (AChE) levels. FQ exposure led to variable degrees of testicular degeneration and significantly increased COX-2 expression in the testis. MXF administration caused a time-dependent reduction in MDA levels. ADA activity was significantly elevated in the CIP group on Day 1 and in the LVX group on Day 14. AChE levels were notably increased in both the LVX and MXF groups on Day 1 compared to controls. These findings suggest that FQ derivatives may exert time-dependent degenerative and inflammatory effects on testicular tissue, highlighting their potential risk for male reproductive toxicity. en_US
dc.description.sponsorship Van Yuzuncu Yil University, Scientific Research Project Commission [TYL-2020-8809] en_US
dc.description.sponsorship This work was supported by the Van Yuzuncu Yil University, Scientific Research Project Commission grant number TYL-2020-8809. en_US
dc.identifier.doi 10.1080/01480545.2025.2565710
dc.identifier.issn 0148-0545
dc.identifier.issn 1525-6014
dc.identifier.scopus 2-s2.0-105019242991
dc.identifier.uri https://doi.org/10.1080/01480545.2025.2565710
dc.identifier.uri https://hdl.handle.net/20.500.14720/28740
dc.language.iso en en_US
dc.publisher Taylor & Francis Ltd en_US
dc.relation.ispartof Drug and Chemical Toxicology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Biochemical Markers en_US
dc.subject COX-2 en_US
dc.subject Fluoroquinolones en_US
dc.subject Rat en_US
dc.subject Testis en_US
dc.title Comparative Histological, Immunohistochemical, and Biochemical Effects of Three Orally Administered Fluoroquinolones in Rats en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 18539360300
gdc.author.scopusid 57201261233
gdc.author.scopusid 54893403000
gdc.author.scopusid 25121451300
gdc.author.wosid Suda, Wataru/Aaf-4469-2019
gdc.author.wosid Kurokawa, Shunya/X-1882-2019
gdc.author.wosid Mikami, Yohei/Grj-8133-2022
gdc.author.wosid Masuoka, Hiroaki/Hgc-7318-2022
gdc.author.wosid Ishii, Chiharu/S-3824-2019
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Yaman, Turan] Van Yuzuncu Yil Univ, Fac Vet Med, Dept Pathol, Van, Turkiye; [Donmez, Fatih; Dogan, Abdulahad] Van Yuzuncu Yil Univ, Fac Pharm, Dept Biochem, Van, Turkiye; [Battal, Abdulhamit] Van Yuzuncu Yil Univ, Fac Pharm, Dept Pharmaceut Biotechnol, Van, Turkiye en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.pmid 41088797
gdc.identifier.wos WOS:001594468300001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files